Market Overview:
The global stem cell therapy for osteoarthritis market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of osteoarthritis, rising awareness about stem cell therapy for treating various diseases, and technological advancements in the field of regenerative medicine. Based on type, the global stem cell therapy for osteoarthritis market is segmented into monotherapy and combination therapy. Monotherapy is further sub-segmented into autologous monotherapy and allogeneic monotherapy. Combination therapy is further sub-segmented into autologous combination therapy and allogeneic combination therapy. Based on application, the global stem cell Therapy for Osteoarthritis Market is segmented into osteoarthritis (unspecified), knee osteoarthritis, shoulder osteoarthritis, hip Osteo arthritis). Regionally, North America dominates the global Stem Cell Therapy For Osteopathy Market followed by Europe due to early adoption of novel technologies in these regions.
Product Definition:
Stem cell therapy is a treatment that uses stem cells to treat diseases or injuries. Stem cells are special cells in the body that can become any other type of cell. They can be used to replace damaged or diseased cells in the body.
Monotherapy:
Monotherapy is a treatment method that involves the administration of one drug or therapy to achieve a desired therapeutic effect. Monotherapy can be used for the treatment of various diseases and disorders such as cancer, arthritis, osteoporosis, etc. The monotherapy market is expected to witness lucrative growth over the forecast period owing to factors such as increasing R&D activities by major players and high demand for effective therapies in oncology and other chronic diseases.
Combination Therapy:
Stem cell therapy has been used to treat several diseases and disorders including Parkinson’s, Alzheimer’s, cancer, and arthritis. However; the use of stem cells for the treatment of osteoarthritis has gained significant traction in recent years. This is primarily due to a substantial increase in R&D efforts aimed at developing novel therapies for OA management over the past decade.
Application Insights:
The knee osteoarthritis segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. The growing geriatric population prone to joint pain and mobility issues is one of the major factors driving this segment. Moreover, increasing awareness about treatment options for knee osteoarthritis is also likely to contribute toward revenue growth.
The hip osteoarthritis segment is expected to grow at a faster rate than that of other applications during the forecast period owing to high unmet medical needs among patients suffering from hip fractures or arthritis-related problems.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D, and increasing prevalence of osteoarthritis. The U.S., which is one of the most developed nations across the globe, holds a major share within this region owing to factors such as advanced healthcare infrastructure and highly skilled professionals working throughout this nation.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as rising disposable income resulting in improved health outcomes; growing awareness regarding stem cell therapy; increase in medical tourism due to availability at affordable costs for treatments performed overseas; and supportive government policies & regulations pertaining towards clinical trials involving human embryonic stem cells (hESC). These aforementioned factors are anticipated to contribute towards regional growth over next eight years.
Growth Factors:
- Increasing prevalence of osteoarthritis across the globe
- Growing geriatric population base that is susceptible to developing osteoarthritis
- Rising awareness about stem cell therapy as an effective treatment for osteoarthritis
- Technological advancements in stem cell therapy treatments for osteoarthritis 5. Availability of government funding and private investments for research on stem cell therapies for treating osteoarthritis
Scope Of The Report
Report Attributes
Report Details
Report Title
Stem Cell Therapy for Osteoarthritis Market Research Report
By Type
Monotherapy, Combination Therapy
By Application
Osteoarthritis (Unspecified), Knee Osteoarthritis, Shoulder Osteoarthritis, Hip Osteoarthritis
By Companies
Mesoblast, Regeneus, U.S. Stem Cell, Anterogen, Asterias Biotherapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Stem Cell Therapy for Osteoarthritis Market Report Segments:
The global Stem Cell Therapy for Osteoarthritis market is segmented on the basis of:
Types
Monotherapy, Combination Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Osteoarthritis (Unspecified), Knee Osteoarthritis, Shoulder Osteoarthritis, Hip Osteoarthritis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mesoblast
- Regeneus
- U.S. Stem Cell
- Anterogen
- Asterias Biotherapeutics
Highlights of The Stem Cell Therapy for Osteoarthritis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monotherapy
- Combination Therapy
- By Application:
- Osteoarthritis (Unspecified)
- Knee Osteoarthritis
- Shoulder Osteoarthritis
- Hip Osteoarthritis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell Therapy for Osteoarthritis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stem cell therapy is a treatment that uses stem cells to help heal or improve the condition of an injury, disease, or other medical condition. Stem cells are special types of cells that can grow and divide many times. This makes them able to repair damaged tissues in the body.nnStem cell therapy is used to treat osteoarthritis (OA). OA is a common type of arthritis caused by damage and inflammation in the joints. The pain from OA can be very severe and can keep people from doing activities they enjoy. Treatment with stem cell therapy may help reduce the pain and inflammation associated with OA, as well as improve joint function over time.
Some of the major companies in the stem cell therapy for osteoarthritis market are Mesoblast, Regeneus, U.S. Stem Cell, Anterogen, Asterias Biotherapeutics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stem Cell Therapy for Osteoarthritis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stem Cell Therapy for Osteoarthritis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stem Cell Therapy for Osteoarthritis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stem Cell Therapy for Osteoarthritis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stem Cell Therapy for Osteoarthritis Market Size & Forecast, 2018-2028
4.5.1 Stem Cell Therapy for Osteoarthritis Market Size and Y-o-Y Growth
4.5.2 Stem Cell Therapy for Osteoarthritis Market Absolute $ Opportunity
Chapter 5 Global Stem Cell Therapy for Osteoarthritis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Stem Cell Therapy for Osteoarthritis Market Size Forecast by Type
5.2.1 Monotherapy
5.2.2 Combination Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Stem Cell Therapy for Osteoarthritis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Stem Cell Therapy for Osteoarthritis Market Size Forecast by Applications
6.2.1 Osteoarthritis (Unspecified)
6.2.2 Knee Osteoarthritis
6.2.3 Shoulder Osteoarthritis
6.2.4 Hip Osteoarthritis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Stem Cell Therapy for Osteoarthritis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Stem Cell Therapy for Osteoarthritis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Stem Cell Therapy for Osteoarthritis Analysis and Forecast
9.1 Introduction
9.2 North America Stem Cell Therapy for Osteoarthritis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Stem Cell Therapy for Osteoarthritis Market Size Forecast by Type
9.6.1 Monotherapy
9.6.2 Combination Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Stem Cell Therapy for Osteoarthritis Market Size Forecast by Applications
9.10.1 Osteoarthritis (Unspecified)
9.10.2 Knee Osteoarthritis
9.10.3 Shoulder Osteoarthritis
9.10.4 Hip Osteoarthritis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Stem Cell Therapy for Osteoarthritis Analysis and Forecast
10.1 Introduction
10.2 Europe Stem Cell Therapy for Osteoarthritis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Stem Cell Therapy for Osteoarthritis Market Size Forecast by Type
10.6.1 Monotherapy
10.6.2 Combination Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Stem Cell Therapy for Osteoarthritis Market Size Forecast by Applications
10.10.1 Osteoarthritis (Unspecified)
10.10.2 Knee Osteoarthritis
10.10.3 Shoulder Osteoarthritis
10.10.4 Hip Osteoarthritis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Stem Cell Therapy for Osteoarthritis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Stem Cell Therapy for Osteoarthritis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Stem Cell Therapy for Osteoarthritis Market Size Forecast by Type
11.6.1 Monotherapy
11.6.2 Combination Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Stem Cell Therapy for Osteoarthritis Market Size Forecast by Applications
11.10.1 Osteoarthritis (Unspecified)
11.10.2 Knee Osteoarthritis
11.10.3 Shoulder Osteoarthritis
11.10.4 Hip Osteoarthritis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Stem Cell Therapy for Osteoarthritis Analysis and Forecast
12.1 Introduction
12.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Stem Cell Therapy for Osteoarthritis Market Size Forecast by Type
12.6.1 Monotherapy
12.6.2 Combination Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Stem Cell Therapy for Osteoarthritis Market Size Forecast by Applications
12.10.1 Osteoarthritis (Unspecified)
12.10.2 Knee Osteoarthritis
12.10.3 Shoulder Osteoarthritis
12.10.4 Hip Osteoarthritis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Stem Cell Therapy for Osteoarthritis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Stem Cell Therapy for Osteoarthritis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Stem Cell Therapy for Osteoarthritis Market Size Forecast by Type
13.6.1 Monotherapy
13.6.2 Combination Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Stem Cell Therapy for Osteoarthritis Market Size Forecast by Applications
13.10.1 Osteoarthritis (Unspecified)
13.10.2 Knee Osteoarthritis
13.10.3 Shoulder Osteoarthritis
13.10.4 Hip Osteoarthritis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Stem Cell Therapy for Osteoarthritis Market: Competitive Dashboard
14.2 Global Stem Cell Therapy for Osteoarthritis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mesoblast
14.3.2 Regeneus
14.3.3 U.S. Stem Cell
14.3.4 Anterogen
14.3.5 Asterias Biotherapeutics
